https://doi.org/10.1016/j.anndiagpath.2010.06.010
O
Omar Hameed
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
134
Papers
2.7K
Citations
27
h-index
60
i10-index
Omar Hameed is an academic researcher from University of Basrah. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Prostate Cancer Treatment and Research. The author has an h-index of 27, co-authored 114 publications.
ORCID: 0000-0001-8725-705XPapers by this author
worksBreast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs
2010 · Annals of Diagnostic Pathology · 43 citations
NF‐κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance
2016 · The Prostate · 38 citations
https://doi.org/10.1002/pros.23195
Using a Higher Cutoff for the Percentage of HER2+ Cells Decreases Interobserver Variability in the Interpretation of HER2 Immunohistochemical Analysis
2008 · American Journal of Clinical Pathology · 22 citations
https://doi.org/10.1309/ketm3hanluqhw7yv
Evaluation of Dual Immunohistochemistry and Chromogenic In Situ Hybridization for HER2 on a Single Section
2011 · American Journal of Clinical Pathology · 19 citations
https://doi.org/10.1309/ajcplnhinn9o6ysf
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: 30% Versus 10% Cutoff for Immunohistochemistry
2008 · Journal of Clinical Oncology · 2 citations
https://doi.org/10.1200/jco.2008.16.6868
Human epidermal growth factor receptor 2 testing in breast cancer: 30% versus 10% cutoff for immunohistochemistry.
2008 · PubMed · 1 citations
https://doi.org/10.5858/2008-132-319a-hegfrt
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat